← Back to Search

NEURESCUE device for Cardiovascular Disease (ARISE Trial)

N/A
Recruiting
Led By David Shavelle, M.D.
Research Sponsored by neurescue
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed up to 1 hour
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the NEURESCUE device, a smart catheter that helps increase blood flow to the heart and brain during cardiac arrest. It is aimed at adults who need extra help beyond usual treatments. The device works by inflating a balloon in the main artery to redirect blood flow to critical areas.

Eligible Conditions
  • Cardiovascular Disease
  • Cardiac Arrest
  • Heart Attack

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed up to 1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed up to 1 hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Return of spontaneous circulation (ROSC)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
The NEURESCUE device will be used as an adjunct to ACLS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NEURESCUE device
2022
N/A
~10

Find a Location

Who is running the clinical trial?

neurescueLead Sponsor
2 Previous Clinical Trials
10 Total Patients Enrolled
David Shavelle, M.D.Principal InvestigatorLong Beach Medical Center
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top